These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 12085695)

  • 41. [B-type natriuretic peptide and congestive heart failure].
    Lommi J
    Duodecim; 2003; 119(14):1301-2. PubMed ID: 12916179
    [No Abstract]   [Full Text] [Related]  

  • 42. Recent advances in natriuretic peptides in congestive heart failure.
    Boerrigter G; Burnett JC
    Expert Opin Investig Drugs; 2004 Jun; 13(6):643-52. PubMed ID: 15174950
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnosis of heart failure using urinary natriuretic peptides.
    Ng LL; Geeranavar S; Jennings SC; Loke I; O'Brien RJ
    Clin Sci (Lond); 2004 Feb; 106(2):129-33. PubMed ID: 13678415
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of natriuretic peptides in cardioprotection.
    Nishikimi T; Maeda N; Matsuoka H
    Cardiovasc Res; 2006 Feb; 69(2):318-28. PubMed ID: 16289003
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Natriuretic peptide system in the human retina.
    Rollín R; Mediero A; Roldán-Pallarés M; Fernández-Cruz A; Fernández-Durango R
    Mol Vis; 2004 Jan; 10():15-22. PubMed ID: 14737067
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Natriuretic peptides in heart valve disease.
    Ray SG
    Heart; 2006 Sep; 92(9):1194-7. PubMed ID: 16251227
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Natriuretic peptide family: new aspects.
    Cea LB
    Curr Med Chem Cardiovasc Hematol Agents; 2005 Apr; 3(2):87-98. PubMed ID: 15853696
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure.
    Tsukamoto O; Fujita M; Kato M; Yamazaki S; Asano Y; Ogai A; Okazaki H; Asai M; Nagamachi Y; Maeda N; Shintani Y; Minamino T; Asakura M; Kishimoto I; Funahashi T; Tomoike H; Kitakaze M
    J Am Coll Cardiol; 2009 Jun; 53(22):2070-7. PubMed ID: 19477358
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of exercise on natriuretic peptides in plasma and urine in chronic heart failure.
    Bentzen H; Pedersen RS; Nyvad O; Pedersen EB
    Int J Cardiol; 2004 Feb; 93(2-3):121-30. PubMed ID: 14975537
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Natriuretic peptides--is it time for clinical use?].
    Nir A; Rein AJ; Hassin Y
    Harefuah; 1999 Mar; 136(5):386-90. PubMed ID: 10914246
    [No Abstract]   [Full Text] [Related]  

  • 51. [Type B natriuretic peptide. Role in heart failure physiopathology, diagnosis, and prognosis].
    Bettencourt P; Azevedo A
    Rev Port Cardiol; 2004 May; 23 Suppl 2():II95-104. PubMed ID: 15222253
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Brain natriuretic peptide in the contemporary management of congestive heart failure.
    Wasywich CA; Whalley GA; Doughty RN
    Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):71-84. PubMed ID: 15723576
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Natriuretic peptide receptor-C regulates coronary blood flow and prevents myocardial ischemia/reperfusion injury: novel cardioprotective role for endothelium-derived C-type natriuretic peptide.
    Hobbs A; Foster P; Prescott C; Scotland R; Ahluwalia A
    Circulation; 2004 Sep; 110(10):1231-5. PubMed ID: 15337698
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Natriuretic peptides and the management of heart failure.
    Calderone A
    Minerva Endocrinol; 2004 Sep; 29(3):113-27. PubMed ID: 15282444
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Water and sodium regulation in chronic heart failure: the role of natriuretic peptides and vasopressin.
    Kalra PR; Anker SD; Coats AJ
    Cardiovasc Res; 2001 Aug; 51(3):495-509. PubMed ID: 11476740
    [No Abstract]   [Full Text] [Related]  

  • 57. Regional sampling and the effects of experimental heart failure in sheep: differential responses in A, B and C-type natriuretic peptides.
    Charles CJ; Prickett TC; Espiner EA; Rademaker MT; Richards AM; Yandle TG
    Peptides; 2006 Jan; 27(1):62-8. PubMed ID: 16095755
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure.
    Kuhn M; Voss M; Mitko D; Stypmann J; Schmid C; Kawaguchi N; Grabellus F; Baba HA
    Cardiovasc Res; 2004 Nov; 64(2):308-14. PubMed ID: 15485690
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structural determinants of natriuretic peptide receptor specificity and degeneracy.
    He XL; Dukkipati A; Garcia KC
    J Mol Biol; 2006 Aug; 361(4):698-714. PubMed ID: 16870210
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Atrial and B-type natriuretic peptides: from the research lab to clinical practice].
    Boomsma F; van den Meiracker AH
    Ned Tijdschr Geneeskd; 2003 Apr; 147(16):743-8. PubMed ID: 12731463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.